CNTB - CIK 0001835268
The table below shows Connect Biopharma Holdings Ltd's cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q1 2025 | Q1 2024 |
|---|---|---|---|
| Operating cash flow | -$16.00M | -$9.96M | -$591.00K |
| Capital expenditure | $0.00 | $81.00K | $0.00 |
| Investing cash flow | $6.00M | -$20.64M | $9.25M |
| Dividends paid | - | - | - |
| Stock buybacks | - | - | - |
| Financing cash flow | $17.62M | $2.00K | $0.00 |
Connect Biopharma Holdings Ltd reported operating cash flow of -$51.21M for fiscal year 2025. That is down 116.9% from -$23.61M in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.